Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics’ CDH17 Autologous CAR‑T Program

B Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study PHILADELPHIA and MELBOURNE, Australia, April 21, 2026 /PRNewswire/ — Minaris, a global…

posteditor
posteditor
Articles: 27298

Other News